There are 2789 resources available
1526MO - GEMMK: A phase I study of gemcitabine (gem) and pembrolizumab (pem) in patients (pts) with leiomyosarcoma (LMS) and undifferentiated pleomorphic sarcoma UPS)
Presenter: Alannah Smrke
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1527MO - Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
Presenter: Nicholas Klemen
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
1759MO - Associations between sarcopenia and gut microbiota in patients (pts) with metastatic renal cell carcinoma (mRCC) and breast cancer (BC)
Presenter: Zeynep Zengin
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
60MO - Gut microbiota and efficacy of immune-checkpoint inhibitors (ICIs) in patients (pts) with advanced solid tumor: SCRUM-Japan MONSTAR-SCREEN
Presenter: Kentaro Sawada
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
LBA68 - Clinical value of pre-treatment T-cell receptors (TCR) repertoire in non-small cell lung cancer (NSCLC) patients treated with single agent immunotherapy
Presenter: Afaf Abed
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1760MO - Impact of immune checkpoint blockade therapy according to CD274 copy number alterations: A retrospective study in the ProfiLER cohort
Presenter: Khalil Hodroj
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1761MO - Defining subset-wise myeloid responses to immune checkpoint blockade in melanoma
Presenter: Rosalin Cooper
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
61MO - Biomarker analysis of men with enzalutamide (enza)-resistant metastatic castration-resistant prostate cancer (mCRPC) treated with pembrolizumab (pembro) + enza in KEYNOTE-199
Presenter: Julie Graff
Session: Mini oral session - Translational research
Resources:
Abstract
Slides
Webcast
1522MO - Hormonal contraception and pregnancy and risk of progression or relapse in desmoid-type fibromatosis (DF)
Presenter: Marion DEBAUDRINGHIEN
Session: Mini oral session - Sarcoma
Resources:
Abstract
Slides
Webcast
LBA53 - Sintilimab plus chemotherapy (chemo) versus chemo as first-line treatment for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma (ORIENT-16): First results of a randomized, double-blind, phase III study
Presenter: Jianming Xu
Session: Mini oral session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast